← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Neurogene NGNE $480M	40	+1	+3%	$314M
52	52 CRISPR Therapeutics CRSP $4.98B	39	+4	+11%	$155M
53	53 Vericel Corp VCEL $2.1B	39	-3	-7%	$36.6M
54	54 DELISTED NeuBase Therapeutics, Inc. Common Stock NBSE	38	-2	-5%	$2.52M
55	55 uniQure QURE $1.56B	34	-5	-13%	$47.5M
56	56 Pluri PLUR $11.9M	32	+3	+10%	$5.63M
57	57 DELISTED BRAINSTORM CELL THERAPUTC BCLI	26	0	0%	$9.23M
58	58 DELISTED Carisma Therapeutics CARM	26	-1	-4%	$2.27M
59	PTE 59 DELISTED PolarityTE, Inc. Common Stock PTE	24	+6	+33%	$11.4M
60	60 CareDx CDNA $3.45B	23	-4	-15%	$7.29M
61	61 Opus Genetics IRD $336M	23	-10	-30%	$10.2M
62	62 Fulgent Genetics FLGT $586M	22	-15	-41%	$19M
63	63 Ocugen OCGN $276M	22	-3	-12%	$20.2M
64	ONCS 64 DELISTED OncoSec Medical Incorporated ONCS	20	-1	-5%	$2.26M
65	65 Capricor Therapeutics CAPR $422M	18	-3	-14%	$630K
66	HTGM 66 DELISTED HTG Molecular Diagnostics, Inc. Common Stock HTGM	18	-3	-14%	$6.59M
67	67 ProQR Therapeutics PRQR $205M	18	-2	-10%	$46.8M
68	ATNX 68 DELISTED Athenex, Inc. Common Stock ATNX	16	+16	–	$9.25M
69	69 Mesoblast MESO $1.81B	16	+3	+23%	$20.1M
70	70 DELISTED BioLife Solutions BLFS	15	0	0%	$813K
71	71 Imunon IMNN $5.89M	15	-2	-12%	$1.28M
72	72 Enlivex Ltd ENLV $4.48M	9	-2	-18%	$211K
73	73 Eterna Therapeutics ERNA $2.53M	9	+1	+13%	$5.36M
74	74 ARK Genomic Revolution ETF ARKG $2.09B	8	+4	+100%	$3.91M
75	75 Benitec Biopharma BNTC $295M	5	+4	+400%	$74K